Eswar Bhimireddy,
Ph.D.
Dr. Bhimireddy holds advanced qualifications including a Doctorate of Philosophy in synthetic organic chemistry from the renowned Indian Institute of Chemical Technology. Subsequently undertaking specialized postdoctoral studies at Harvard University operating under the supervision of Nobel Laureate Professor E.J. Corey, he has amassed over 15 years’ experience across the disparate yet interrelated realms of academia, pharmaceutical industry engagement, and healthcare sector contributions. Dr. Bhimireddy’s diverse portfolio encompasses pivotal research striving in the multifarious domains of drug discovery, antibody-drug conjugation schemata, peptide synthesis methodologies, and assorted small molecular paradigms, with far-reaching import for pharmaceutical and biomedical applications. He has been an author and co-author of over a decade of publications, including highly ranked the Journal of the American Chemical Society (JACS). Additionally, Dr. Bhimireddy holds commercial patents in healthcare and pharmaceutical research, underscoring his innovative contributions to the field
Hari Naga Prasada Reddy Chittireddy,
Ph.D.
Dr. Hari Naga Prasada Reddy Chittireddy stands as a distinguished luminary within the pharmaceutical and life sciences arena, celebrated for his mastery in both technical and commercial spheres. With a Ph.D. in Chemistry Dr. Hari brings a wealth of knowledge to his role as Chief Commercial Officer / Director at Auxiliary Bio Sciences. His career is distinguished by notable achievements, including spearheading pivotal initiatives, cultivating invaluable stakeholder relationships, and executing projects with precision and finesse. Over two decades, Dr. Hari has consistently demonstrated exceptional strategic insight and a talent for leading cross-functional teams to unprecedented success. He is an expert in green-field projects, specializing in CRO, Generic drug product, drug substance and manufacturing industries. His expertise in analytical research, chromatography and mass spectrometry is unparalleled, further enhancing his contributions to the industry. His dedication to innovation and excellence shines through in his extensive publications and transformative contributions. In the realm of visionary leadership, he stands as a beacon of distinction, guiding Auxiliary Bio Sciences towards unparalleled prosperity and eminence. Dr. Hari's vision is to leverage knowledge and experience for global health advancement. With expertise in the pharmaceutical industry, he aims to drive initiatives that elevate healthcare standards worldwide, benefiting individuals and communities.
Venkata S. A. Pisipati,
Ph.D.
Dr. Pisipati lends Auxiliary Biosciences his more than two
decades of expertise focused especially on small molecular drug discovery
pertaining to anti-infectives. In possession of a Doctorate of Philosophy in
Medical Microbiology from the University of Manitoba, his guidance and hands-on
leadership have facilitated meaningful progressions. Notably, groundbreaking
inquiries undertaken at Harvard University operating under the tutelage of
Professors Andrew G. Myers and E. J. Corey, Nobel Laureate, have yielded
publications in prestigious peer-reviewed publications including Nature, Nature
Communications, and the highly ranked Journal of the American Chemical Society.
His pioneering work designing fully synthetic antibacterial agents has
attracted widespread commendation. Dr. Pisipati’s commitment to innovation and
collaborative spirit continue enabling therapeutic breakthroughs.
Rajith Singh Manan,
Ph.D.
Dr. Manan currently holds a research scientist position at the esteemed Massachusetts Institute of Technology where he participates in close collaboration with distinguished faculty such as Professors Robert S. Langer and Daniel Anderson of Moderna and Crisper Therapeutics renown. Specializing in diverse bioscience applications including mRNA delivery methodologies, gene editing technologies, and complex molecular synthesis, he holds advanced qualification with a Doctorate of Philosophy from North Dakota State University. Impacting work appearing across 12 peer-reviewed journals incorporates contributions to the highly prestigiously ranked Nature Biotechnology and Nature Biomedical Engineering. Additionally, Dr. Manan owns two patents exemplifying his expertise in designing biodegradable lipid constructs for mRNA delivery and CRISPR-Cas9 purposes, continuing to facilitate therapeutic innovations through his research acumen and teamwork proclivities.
Naresh Akavaram,
M.Sc
With an illustrious 20-year career spanning CRO Business,
Discovery Research, and Process Research and Development, Naresh Akavaram's
expertise has left an indelible mark on renowned organizations such as Curia
Singapore, Sai Life Sciences, Aurigene Life Sciences, Aragen, and BASR Fine
Chemicals. Akavaram's profound understanding of the pharmaceutical and life
sciences sectors positions him as an invaluable asset to Auxiliary Biosciences.